Netcall (NET) Competitors GBX 85.20 -2.30 (-2.63%) (As of 11:25 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades NET vs. DOCS, YOU, WIX, SST, CNIC, API, SRAD, GVP, ARBB, and SLPShould you be buying Netcall stock or one of its competitors? The main competitors of Netcall include Dr. Martens (DOCS), YouGov (YOU), Wickes Group (WIX), Scottish Oriental Smaller Cos (SST), CentralNic Group (CNIC), abrdn Property Income Trust (API), Stelrad Group (SRAD), Gabelli Value Plus+ Trust (GVP), Arbuthnot Banking Group (ARBB), and Sylvania Platinum (SLP). These companies are all part of the "computer software" industry. Netcall vs. Dr. Martens YouGov Wickes Group Scottish Oriental Smaller Cos CentralNic Group abrdn Property Income Trust Stelrad Group Gabelli Value Plus+ Trust Arbuthnot Banking Group Sylvania Platinum Dr. Martens (LON:DOCS) and Netcall (LON:NET) are both small-cap consumer cyclical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment, earnings and community ranking. Do analysts prefer DOCS or NET? Netcall has a consensus target price of GBX 130, indicating a potential upside of 48.57%. Given Netcall's higher probable upside, analysts clearly believe Netcall is more favorable than Dr. Martens.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dr. Martens 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ANetcall 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, DOCS or NET? Dr. Martens has higher revenue and earnings than Netcall. Dr. Martens is trading at a lower price-to-earnings ratio than Netcall, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDr. Martens£877.10M0.63£69.20M£0.07818.57Netcall£37.42M3.86£5.36M£0.032,916.67 Does the media prefer DOCS or NET? In the previous week, Dr. Martens had 3 more articles in the media than Netcall. MarketBeat recorded 3 mentions for Dr. Martens and 0 mentions for Netcall. Dr. Martens' average media sentiment score of 0.91 beat Netcall's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the media. Company Overall Sentiment Dr. Martens Positive Netcall Neutral Is DOCS or NET a better dividend stock? Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 5.2%. Netcall pays an annual dividend of GBX 1 per share and has a dividend yield of 1.1%. Dr. Martens pays out 4,285.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Netcall pays out 3,333.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Which has more risk and volatility, DOCS or NET? Dr. Martens has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Comparatively, Netcall has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Does the MarketBeat Community favor DOCS or NET? Netcall received 149 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 57.76% of users gave Netcall an outperform vote. CompanyUnderperformOutperformDr. MartensOutperform Votes1191.67% Underperform Votes18.33%NetcallOutperform Votes16057.76% Underperform Votes11742.24% Is DOCS or NET more profitable? Netcall has a net margin of 14.32% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 17.92% beat Netcall's return on equity.Company Net Margins Return on Equity Return on Assets Dr. Martens7.89% 17.92% 8.12% Netcall 14.32%15.24%4.62% Do insiders and institutionals believe in DOCS or NET? 69.5% of Dr. Martens shares are owned by institutional investors. Comparatively, 69.3% of Netcall shares are owned by institutional investors. 4.4% of Dr. Martens shares are owned by insiders. Comparatively, 11.5% of Netcall shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryDr. Martens beats Netcall on 10 of the 19 factors compared between the two stocks. Ad InvestorPlace“A very dark day is coming to America”Wall Street Legend on Economy: "If you knew what I know, you'd be terrified too." Something huge is headed to America's shores – and it scares the hell out of Wall St. legend Louis Navellier. When it makes landfall, its impact will be more violent and more severe than any financial crisis we've ever seen… "No matter how prepared you think you are, you aren't prepared enough," he warns.Click here to see his official warning. Get Netcall News Delivered to You Automatically Sign up to receive the latest news and ratings for NET and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NET vs. The Competition Export to ExcelMetricNetcallSoftware IndustryComputer SectorLON ExchangeMarket Cap£144.30M£2.37B£22.26B£1.40BDividend Yield0.92%3.19%2.72%11.72%P/E Ratio2,916.67740.50256.741,556.19Price / Sales3.864,669.14570.38175,555.37Price / Cash7.3516.1230.7132.89Price / Book3.6512.846.832.82Net Income£5.36M£29.73M£661.80M£152.20M7 Day Performance-0.68%-0.64%1.65%-0.07%1 Month Performance-3.21%-0.03%4.95%2.14%1 Year Performance1.92%61.58%25.54%17.41% Netcall Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NETNetcall1.58 of 5 starsGBX 85.20-2.6%GBX 130+52.6%+2.3%£140.50M£37.42M2,840.003,220DOCSDr. MartensN/AGBX 56.30-0.5%N/A-58.7%£541.45M£877.10M804.29890Dividend CutPositive NewsYOUYouGov3.4301 of 5 starsGBX 437-3.5%GBX 905+107.1%-39.0%£510.29M£270M2,185.003,060Gap UpWIXWickes Group2.5232 of 5 starsGBX 175.20+1.5%GBX 180+2.7%+25.6%£415.38M£1.53B1,460.005,930Positive NewsSSTScottish Oriental Smaller CosN/AGBX 1,530+3.0%N/A+14.8%£360.32M£53.86M916.17320CNICCentralNic GroupN/AGBX 123.20+2.0%N/A-7.1%£339.82M£790.04M-12,660.00100APIabrdn Property Income TrustN/AGBX 61.10-0.7%N/A+25.9%£232.93M£32.44M-3,055.001,310Gap UpHigh Trading VolumeSRADStelrad GroupN/AGBX 154+1.3%N/A+61.0%£196.12M£294.27M1,283.332,960Gap DownGVPGabelli Value Plus+ TrustN/AGBX 158-7.6%N/AN/A£155.29MN/A0.00310Gap DownARBBArbuthnot Banking GroupN/AGBX 932.50-0.8%N/A-0.8%£150.97M£179.17M496.01799Gap UpSLPSylvania PlatinumN/AGBX 48.50-1.0%N/A-36.9%£126.88M£81.71M2,425.00160 Related Companies and Tools Related Companies: DOCS Competitors YOU Competitors WIX Competitors SST Competitors CNIC Competitors API Competitors SRAD Competitors GVP Competitors ARBB Competitors SLP Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:NET) was last updated on 10/4/2024 by MarketBeat.com Staff From Our PartnersHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | Sponsored“A very dark day is coming to America”Wall Street Legend on Economy: "If you knew what I know, you'd be terrified too." Something huge is headed ...InvestorPlace | SponsoredAI expert reveals new Nvidia predictionEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Netcall plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Netcall With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.